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Abstract
As with many viruses, rabies virus (RABV) infection induces type I interferon (IFN) production within the infected host cells.
However, RABV has evolved mechanisms by which to inhibit IFN production in order to sustain infection. Here we show that
RABV infection of dendritic cells (DC) induces potent type I IFN production and DC activation. Although DCs are infected by
RABV, the viral replication is highly suppressed in DCs, rendering the infection non-productive. We exploited this finding in
bone marrow derived DCs (BMDC) in order to differentiate which pattern recognition receptor(s) (PRR) is responsible for
inducing type I IFN following infection with RABV. Our results indicate that BMDC activation and type I IFN production
following a RABV infection is independent of TLR signaling. However, IPS-1 is essential for both BMDC activation and IFN
production. Interestingly, we see that the BMDC activation is primarily due to signaling through the IFNAR and only
marginally induced by the initial infection. To further identify the receptor recognizing RABV infection, we next analyzed
BMDC from Mda-52/2 and RIG-I2/2 mice. In the absence of either receptor, there is a significant decrease in BMDC
activation at 12h post infection. However, only RIG-I2/2 cells exhibit a delay in type I IFN production. In order to determine
the role that IPS-1 plays in vivo, we infected mice with pathogenic RABV. We see that IPS-12/2 mice are more susceptible
to infection than IPS-1+/+ mice and have a significantly increased incident of limb paralysis.
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Introduction
Type I interferon (IFN) was first identified as a ‘‘factor’’ that
rendered cells resistant to viral infection [1]. It is now known that
following viral infection, cells induce type I IFN, which in turn
upregulates the expression of numerous antiviral proteins [2]. This
class of cytokines is comprised of several genes including multiple
IFN-a genes, a single IFN-ß gene, and the less well-defined IFN-v,
-e,- t,- d, and -k (for review [3]). In addition to having antiviral
functions, type I IFNs play a part in activating the adaptive
immune response following infection [4,5,6]. For instance, IFN-a/
ß can strengthen the innate immune response by activating
antigen presenting cells (APC). Additionally, following maturation
in the presence of type I interferon and GM-CSF, monocyte-
derived DCs more effectively stimulate an antigen-specific CD8
+
T cell response than when differentiated with GM-CSF alone [7].
Viral infection can trigger the type I IFN response via various
pattern recognition receptors (PRR), namely Toll-like receptors
(TLR) and RIG-I-like receptors (RLR). In the case of negative
stranded RNA viruses, the members of the TLR family that are
generally involved in viral recognition, TLR-3 and TLR-7, are
found on the endosomal membrane. To initiate the signaling
cascade, TLR-3 binds double stranded RNA molecules [8],
whereas TLR-7 recognizes immunomodulatory compounds (ie-
imiquimod) [9] or single-stranded RNA molecules [10]. Although
negative stranded RNA viruses do not produce double stranded
RNA as part of their normal replication cycle, it is likely that
abnormal replication products resulting from errors by viral RNA-
dependent RNA polymerases give rise to some level of double
stranded RNA in virus-infected cells [11]. TLR-3 and TLR-7
initiate signaling though different adaptor molecules, Trif and
MyD88, respectively; however, the pathways converge on the
phosphorylation of IRF-3. Following phosphorylation, IRF-3
forms protein dimers, which allow for its transport into the
nucleus where it can bind to the IFN-ß promoter [12].
Alternatively, RNA viruses can be recognized in the cytoplasm
by RLRs, namely RIG-I and Mda-5 [13]. These helicase-like
proteins recognize double-stranded RNA and 59 tri-phosphate
groups [14]. In the case of rabies virus (RABV), the negative
stranded RNA virus of interest in this study, the leader RNA
remains unmodified [15,16] and thus provides a potential ligand
for these RLRs. Signaling by RIG-I and Mda-5 is mediated
through the mitochondria-bound protein IPS-1, which is also
referred to as MAVS, Cardif, or VISA [17,18,19,20]. Similar to
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activation and nuclear translocation of IRF-3 [19].
Rabies virus is a member of the Rhabdoviridae family. RABV
has a relatively simple genome, comprised of just 5 proteins: the
nucleoprotein, phosphoprotein (P), matrix protein, glycoprotein
and the RNA dependent RNA polymerase. Infection with RABV
can induce IFN-a/ß production rapidly in vivo. Furthermore, it
was seen that a mouse’s ability to induce type I IFN, as measured
by serum concentrations 4 days post infection, positively correlates
to the animal’s resistance to RABV [21]. The type I IFN response
is also important in driving immunity, as mice injected with anti-
mouse IFN-a/ß antibody prior to infection with RABV were more
sensitive to the virus than mice injected with a control antibody
[22]. However, RABV has the ability to antagonize type I IFN
induction [23]. Thus, shortly after infection of fibroblast cells,
RABV-P prevents IRF-3 phosphorylation in order to suppress
IFN-a/ß production [23].
Although IFN is induced after RABV infection, RABV is able to
suppress the IFN response shortly after infection. Therefore, in
order to study the receptors responsible for the initial induction of
IFN, several groups have used recombinant viruses with lower
levels of RABV-P. Using this method, it was determined that IFN-
ß promoter activity was seen following recombinant RABV
infection of VERO cells transfected with wildtype RIG-I, but
not in cells transfected with dominant-negative mutant RIG-I
[24], thus indicating a role for RIG-I in mounting an innate
immune response to RABV. Additionally, following infection of
human postmitotic neurons with RABV, Prehaud et al. saw an
increased production of IFN-ß and TLR-3 mRNAs [25].
Furthermore, the expression of TLR-3 on cerebellar cortex tissues
of individuals that had died of rabies, but not on an individual that
died of cardiac arrest, verify the viral induced expression of TLR-3
in human brains in vivo [26]. This upregulation of TLR-3 following
infection suggests a possible role for TLR-3 signaling in the innate
recognition of RABV; however, TLR-3 activation needs to be
further studied to conclusively define such a role. Although these
results hint at the receptors responsible for interferon expression,
there is no evidence that other PRR receptors, such as TLR-7 and
Mda-5, do not also play a role. Furthermore, since the
recombinant viruses used in some of these studies exhibit
decreased pathogenicity, it is possible that a wildtype virus may
act differently following infection.
In order to study the IFN-inducing pathways triggered by
RABV, we needed to identify a cell type in which RABV-P is
unable to antagonize type I IFN signaling. Of note, it has been
seen that following infection of dendritic cells (DCs) with influenza,
another negative stranded RNA virus, the DCs become infected,
but this infection is non-productive [27]. Here, we sought to
determine whether APCs were productively infected with RABV.
Similar to previous reports that human DCs are susceptible to
RABV infection [28,29], we saw that mouse DCs became infected;
however we also observed that very little viral progeny was
released due to limited viral replication. Due to the overall
suppression of viral transcription in RABV infected DCs there are
presumably low levels of RABV-P that may not be able to inhibit
interferon induction. Thus, we decided to utilize infection of DC
to study the IFN-inducing capabilities of RABV and found that
RLRs are responsible for viral recognition in DCs.
Results
RABV infection of antigen presenting cells results in type
I IFN production
It has been previously shown that RABV-P can inhibit the
phophorylation of IRF-3 in fibroblast cells [23], thus crippling the
induction IFN-a/ß. However, RABV is able to infect a variety of
cells including neurons [30] and antigen presenting cells (APC)
[28,29] in addition to fibroblasts. Thus, we wanted to determine
whether RABV is able to inhibit IFN signaling in other cell types
including DCs, which are known to induce the adaptive immune
response.
In order to check for type I IFN production, we first infected a
variety of cell types including fibroblasts (BSR), neuronal cells
(NA), macrophages (Raw264.7) and DCs (JAWSII) with a RABV
vaccine strain-based vector, SPBN. Following infection with
RABV, cell supernatants were collected and subsequently UV-
treated in order to deactivate any infectious virus but retain
secreted cellular proteins, such as type I IFN. We then transferred
the supernatants to reporter cells, which are sensitive to IFN.
Twenty-four hours after supernatant transfer, reporter cells were
infected with recombinant vesicular stomatitis virus expressing
GFP (VSV-GFP, [31]) for 5–8h. VSV replication is highly
sensitive to type I IFN [32], and thus, in the presence of type I
IFN, the replication of VSV is suppressed [4]. Following infection
with RABV, macrophages as well as DCs, but not fibroblasts or
neuronal cells, produce type I IFN that inhibits VSV-GFP
replication, as indicated by the lack of GFP expression
(Figure 1A). Of note, when BSR, NA, Raw264.7, or JAWSII
cells are originally treated with UV-deactivatecd RABV, the
supernatants from these cells are unable to block VSV replication
(Figure 1B); therefore, IFN is secreted only after RABV
replication.
In order to account for the increased amounts of type I IFN
produced following RABV infection of macrophages and DCs
when compared to the amount produced by fibroblast and
neuronal cells, we did a one-step growth curve following infection
of the various cell types. Supernatants from infected cells was
titered on BSR cells, which are insensitive to type I IFN [4]. We
detected that, although all four cell types were infected, only BSR
and NA cells produce infectious virus (Figure 2A). There are two
possible explanations for the defect in viral production observed
here: either a block in viral replication or a defect in viral
Author Summary
Rabies virus (RABV) is a neurotropic RNA virus responsible
for the deaths of the at least 40,000 to 70,000 individuals
globally each year. However, the innate immune response
induced by both wildtype and vaccine strains of RABV is
not well understood. In this study, we assessed the pattern
recognition receptors involved in the host immune
response to RABV in bone marrow derived dendritic cells
(DC). Our studies revealed that Toll like receptor (TLR)
signaling is not required to induce innate responses to
RABV. On the other hand, we see that IPS-1, the adaptor
protein for RIG-I like receptor (RLR) signaling, is essential
for induction of innate immune responses. Furthermore,
we found that RIG-I and Mda-5, both RLRs, are able to
induce DC activation and type I interferon production. This
finding is significant as we can target unused pattern
recognition receptors with recombinant RABV vaccine
strains to elicit a varied, and potentially protective,
immune response. Lastly, we show that IPS-1 plays an
important role in mediating the pathogenicity of RABV and
preventing RABV associated paralysis. Overall, this study
illustrates that RLRs are essential for recognition of RABV
infection and that the subsequent host cell signaling is
required to prevent disease.
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PLoS Pathogens | www.plospathogens.org 2 July 2010 | Volume 6 | Issue 7 | e1001016Figure 1. RABV infection of APCs, but not fibroblasts, induces type I IFN production. BSR, NA, Raw264.7, or JAWSII cells were infected with
RABV (A) or UV-deactivated RABV (B) and the supernatant from the infected cells was UV-deactivated. Reporter cells were pre-treated with the UV-
deactivated supernatant (diluted 1:10) for 24h and then infected with VSV-GFP for 5h. Fluorescence indicates viral replication, and thus, lack of type I
IFN. Photos are representative of two independent experiments.
doi:10.1371/journal.ppat.1001016.g001
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in fibroblast and dendritic cell lines we used quantitative PCR. In
fibroblast cells, we saw that the amount of RABV-N messenger
RNA (mRNA) transcripts increased an average of 1.95 logs from
8 hours post infection (hpi) to 48 hpi. Similarly, the quantity of
RABV-N genomic RNA transcripts (gRNA) increased an average
of 1.2 logs from 8 hpi to 48 hpi. This data indicates that following
infection of fibroblast cells both viral transcription (mRNA) and
replication (gRNA) occurs. On the other hand, when looking at
the quantity of RABV-N found in dendritic cells following
infection we see that there was no increase in the number of
mRNA or gRNA viral transcripts when comparing 8hpi to 48 hpi.
Thus, it appears that RABV is able to enter APCs, but only limited
viral transcription occurs following entry.
It is reasonable to assume that decreased levels of transcription
might result in low levels of RABV-P. It has been previously shown
that recombinant RABV expressing low amounts of RABV-P is
unable to inhibit type I IFN induction [23]. Furthermore, we show
by Western blotting that cell lysate from RABV infected JAWSII
cells contained undetectable levels of RABV P 48hpi (Figure 2B).
On the other hand, we were able to detect RABV P in lysates from
infected BSR cells as early as 12 hpi after infection. This results
support the conclusion that a very low level of RABV P within
infected APCs is not able to block the induction of type I IFN and
therefore is responsible for the increase in type I IFN production
by these cells following infection.
In order to better understand the interaction of RABV with host
cells following infection, we sought to identify the pathway(s)
responsible for type I IFN induction in infected cells. Since we
detected that DCs make large amounts of IFN following RABV
infection we decided to use bone marrow derived DCs (BMDC) in
our studies. To differentiate BMDCs, we cultured the cells in the
presence of 10 ng/ml GM-CSF. After 7 days the majority of cells
have matured to DCs as shown by the expression of
CD11b
+CD11c
+ (Figure 3). In order to identify the PRR that
recognizesRABV,weisolated BMDC frommicedeficient invarious
signaling components of PRR pathways. In each experiment, cells
were stimulated, and the CD11c
+ cell population (Figure 3) was
analyzed for production of type I IFN and expression of CD86, a co-
stimulatory molecule that is upregulated on activated DCs.
Figure 2. Infection of APCs is non-productive. (A) NA, BSR, Raw264.7, and JAWSII cells were infected with RABV at an MOI=10. A one-step
growth curve was generated by titering infectious RABV in the supernatant of the infected cells at various hours post infection as indicated. (B)
Western blot analysis. BSR or JAWSII cells were infected with RABV (MOI of 10) and lysed 12, 24 or 48 h later. Proteins were separated by SDS-PAGE
and subjected to Western blotting with mouse polyclonal antibodies specific for RABV (strain N2c), or a mouse monoclonal against actin (Actin). The
RABV proteins N, P, and M are indicated.
doi:10.1371/journal.ppat.1001016.g002
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infection is independent of TLR-3 and MyD88 signaling
First, we analyzed the role that TLR signaling plays in BMDC
activation and type I IFN production following a RABV infection.
It has been previously reported that following infection of human
postmitotic neurons with RABV, there is an increased production
of IFN-ß and TLR-3 mRNAs. In addition, treatment of neurons
with poly(I:C), a TLR-3 agonist, generated a similar cytokine
profile to that which was seen following RABV infection [25].
Thus, we differentiated BMDCs from TLR-32/2 and congenic
wildtype mice and infected the cells with RABV. We then
analyzed the infected cells for the presence of CD86 (Figure 4A).
As shown in Figure 4C, there is no significant difference in the
expression of CD86 on the cell surface of RABV infected BMDCs
derived from TLR-32/2 or wildtype mice. As expected, TLR
ligands that signal via other TLR receptors, namely TLR-4 (LPS),
TLR-9 (ODN1826), and TLR-7/8 (R848), equally activate
BMDCs derived from wildtype (wt) or TLR-32/2 mice.
Interestingly, poly(I:C), a known ligand for TLR-3, was able to
activate BMDC isolated from TLR-32/2 mice as well as wt
mice. However, it has been previously shown that poly(I:C) can
also signal through Mda-5 and that Mda-5 is the dominant
Figure 3. BMDC differentiation and gating. BMDC were derived from various mice by culture in media containing 10ng/ml GM-CSF for 7 days.
(A) Following culture, the majority of viable cells (as determined by forward and side scatter) were CD11b+CD11c+. (B) When analyzing activation
state or infection rates of BMDCs following stimulation the cells were first gated for viability (using forward and side scatter) and then gated for
CD11c expression. Only CD11c+ cells were used in analysis. One representative Balb/c mouse is shown here, but this gating strategy was consistently
used for all BMDC samples.
doi:10.1371/journal.ppat.1001016.g003
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stimulation in BMDCs [33,34]. As the RLR pathway remains
intact in TLR-32/2 mice, BMDC activation in TLR-32/2 cells
following poly(I:C) stimulation is not inexplicable, but rather
highlights the need for a better TLR-3 agonist. Taken as a whole
and based on the fact that that RABV infection activated BMDC
derived from both wt and TLR-32/2 mice equally, we conclude
that TLR-3 signaling is not required for the activation of BMDCs
following a RABV infection.
To our knowledge, TLR-7 has never been investigated in the
context of a RABV infection and thus the role that it plays in type I
IFN induction and DC activation following RABV infection is
unknown. To analyze the function that TLR-7 has in the induction
of type I IFN and DC activation, we isolated BMDCs from
MyD882/2 and C57BL/6 mice. We detected an equal upregula-
tion of CD86 on BMDCs from MyD882/2 and wildtype mice
(Figure 4B). As expected, activation of MyD882/2 BMDCs is
significantly reduced following stimulation with ODN1826 and
R848, ligands for TLR-9 and TLR-7/8 respectively, both of which
signal via MyD88 [35] (Figure 4D). Thus we conclude that, similar
to TLR-3 signaling, the activation of BMDCs following a RABV
infection occurs independently of MyD88 signaling.
Figure 4. DC activation following a RABV infection occurs independent of TLR signaling. BMDC derived from TLR-32/2 mice (A and C) or
MyD882/2 mice (B and D). (A–B) CD86 upregulation following RABV infection of BMDCs was monitored at 12, 24, and 48 hours post infection. One
representative knock-out and wildtype mouse is shown at 12hpi. (C–D) For each sample the fold increase in activation was determined by dividing
the geometric mean fluorescent intensity (MFI) of the sample by the MFI of the uninfected sample. (C) Data is from two independent experiments
and each point is representative of BMDC from one mouse. (D) Data is from four independent experiments and each point is representative of BMDC
from two pooled mice. Statistical significance was determined by T-test analysis and any significance is indicated, ***p,0.001.
doi:10.1371/journal.ppat.1001016.g004
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have an impact on type I IFN production, supernatant from
infected BMDCs was collected at various times post infection, and
a VSV-sensitivity assay was performed. As seen with BMDC
activation, both TLR-3 and MyD88 are dispensable in the
induction of type I IFN (Table 1). We did not detect any VSV-
GFP replication on reporter cells following pre-treatment with
supernatant from TLR-32/2, MyD882/2, or wildtype BMDC,
indicating the presence of type I IFN in the supernatant.
Induction of type I IFN and DC activation following RABV
infection requires the IPS-1 pathway
Having excluded TLRs as the required receptors mediating
BMDC activation and type I IFN production, we next looked at the
potential role for RLR signaling. Hornung et al. showed that a
recombinant RABV expressing low levels of RABV-P signals via
RIG-I to induce IFN-ß promoter activity following infection.
Furthermore, it was shown that the 59-triphosphate on the leader
sequence of RABV was the ligand for RIG-I [24]. To determine
whether the RIG-I pathway is also activated in DCs following RABV
infection, we isolated BMDCs from IPS-1+/+, +/2,o r2/2 mice.
Our results indicate that following infection with RABV, IPS-1+/+
and IPS-1+/2 BMDCs express high levels of CD86 on their surface
(Figure 5A–B). Of note, IPS-1+/2 BMDCs are slightly less activated
then IPS-1+/+ cells. On the other hand, IPS-12/2 BMDCs express
significantly lower levels of CD86 on their surface at all time points
(Figure 5A–B). The TLR ligands LPS, ODN1826, and R848 equally
activated all IPS-1 BMDC samples, indicating that the defect in the
IPS-1 2/2 B M D C si ss p e c i f i ct ot h eR L Rp a t h w a y s( F i g u r e5 B ) .A s
such, when cellsarestimulated with RLR agonists,thereis a defect in
the activation of IPS-12/2BMDCs when compared to IPS-1+/+ or
+/2 BMDCs. We see a low CD86 upregulation following both
poly(I:C) stimulation and infection with a NS1-deficient strain of
influenza (DNS1/PR8) (Figure 5B). It has been reported previously
that poly(I:C) can signal via Mda-5 [33] and DNS1/PR8 signals
exclusively via RIG-I [34]. Taken together this data indicates that
BMDC activation is dependent on IPS-1 signaling following a RABV
infection.
In order to determine whether type I IFN production by
BMDC is also dependent on IPS-1 mediated signaling, we assayed
for the presence of type I IFN in the supernatants of infected IPS-1
BMDCs by VSV-GFP sensitivity assays and quantified the amount
of IFN-ß by ELISA. It was seen that supernatant obtained from
IPS-1+/+ and IPS-1+/2 BMDCs infected with RABV was able to
inhibit VSV-GFP replication, and thus contained type I IFN. On
the other hand, the VSV-GFP replication on reporter cells was not
inhibited by pre-treatment with supernatants from RABV infected
IPS-12/2 BMDCs (Figure 5C). Likewise, IPS-1 +/+ BMDCs
produce on average 250 pg/ml IFN-ß while the IPS-12/2
BMDCs produced less than 16.7 pg/ml, if any, IFN-ß (Figure 5C).
These results indicate that RABV infected IPS-12/2 BMDCs do
not secrete type I IFN. Also consistent with the results seen for
BMDC activation, IPS-12/2 cells stimulated with RLR agonists
produced less type I IFN compared to IPS-1+/+ or +/2 BMDCs
(Table 2).
It has been shown that IPS-1 mediated pathways are also
capable of activating the NF-kB signaling cascade [36]. Thus, we
quantified the amount of IL-6 in the supernatant of RABV
infected BMDC isolated from IPS-1+/+, +/2 and 2/2 mice
(Figure 5D). We see that there is a significant decrease in IL-6
produced by IPS-12/2 BMDCs compared to IPS-1+/+ BMDCs.
However, IPS-12/2 cells do secrete some IL-6 following
infection with RABV, and thus, the use of IPS-1 independent
pathways to induce NF-kB activation, in contrast to type I IFN
activation, seems to be utilized.
IPS-1 is the adaptor molecule for both Mda-5 and RIG-I
Mda-5 mediated induction of IFN-ß has been described to
occur in response to plus-stranded RNA viruses like picornavirus-
es, whereas it is reported that RIG-I is responsible for type I IFN
induction in response to rhabdovirus infection [34]. However, the
function of Mda-5 in the innate immune response to rhabdovir-
idae has not yet been elucidated. Furthermore, the role of these
PRRs following a RABV infection in DCs remains unknown.
Therefore we wanted to determine which of the two receptors
recognizes RABV. For this approach, BMDCs from Mda-52/2
mice and RIG-I2/2 mice were isolated. As shown in Figure 6A,
Mda-52/2 BMDCs express high levels of CD86 on their surface
at 24 and 48 hpi. Of note, there is a significant reduction of CD86
surface expression on Mda-52/2 BMDCs at 12 hpi when
compared to wildtype cells. Likewise, RIG-I 2/2 BMDCs also
have a defect in BMDC activation at 12 hpi, while CD86
expression at 24 and 48 hpi is equal for RIG-I2/2 and RIG-I
+/+ cells (Figure 6B). In addition, it appears that while Mda-5
2/2 cells are able to induce type I IFN expression 12 hpi,
RIG-I2/2 cells have an early defect in type I IFN induction.
Importantly, by 48hpi, RIG-I2/2 BMDC do produce enough
type I IFN to suppress VSV-GFP replication (Figure 6C). This
indicates that RABV can induce BMDC activation and type I IFN
via both Mda-5 and RIG-I ligation. Furthermore, any perturba-
tion in IPS-1 mediated signaling cascades seems to affect the early
response (12hpi) to RABV.
RABV infection by itself is sufficient to induce type I IFN
production, while positive feedback is necessary for
sufficient BMDC activation
Once type I IFN is produced, it will further activate the infected
cell via autocrine signaling through IFNAR. Ligation of the
Table 1. Level of VSV-GFP replication on reporter cells following pre-treatment with UV-inactivated supernatants from RABV
infected BMDC.
SPBN, 12h uninfected, 12h UV-killed SPBN, 12h SPBN, 24h uninfected, 24h SPBN, 48h uninfected, 48h
C57BL/6 2 ++ ++ 2 ++ 2 ++
MyD882/2 2 ++ ++ 2 ++ 2 ++
BL6129SF1/J 2 ++ ++ 2 ++ 2 ++
TLR-32/2 2 ++ ++ 2 ++ 2 ++
2: Less than 1% of reporter cells are infected.
++: 100% of reporter cells are infected.
doi:10.1371/journal.ppat.1001016.t001
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nates in the upregulation of antiviral genes. In addition to antiviral
genes, Jak/STAT signaling also upregulates proteins required for
type I IFN induction, thus providing a positive feedback for the
type I IFN pathway [2]. In order to determine how much IFN
induction is directly related to RABV infection and how much is
due to positive feedback that is driven by IFN-a/ß production, we
infected BMDCs derived from IFNAR2/2 mice, which elimi-
nates the contribution of positive feedback. Interestingly, BMDC
isolated from IFNAR2/2 mice produce enough type I IFN to
block VSV-GFP replication on reporter cells after 12, 24, and 48 h
(Figure 7A). However, we detected a significant decrease in the
CD86 cell surface expression of IFNAR2/2 BMDC when
compared to wt BALB/c mice (Figure 7B–C). Thus, although
RABV infection is sufficient to induce type I IFN, the cells need an
amplification signal in order to undergo maturation. Additionally,
we see a significantly greater infection by RABV in IFNAR2/2
cells, presumably due to their inability to induce antiviral gene
expression (Figure 7D).
Role of IPS-1 signaling in vivo
Lastly, we wanted to determine the impact that the RIG-I
and Mda-5 pathways play in the in vivo response to RABV
utilizing IPS-1 2/2 m i c e .I n t e r e s t i n g l y ,w ed e t e c t e dt h a t
IPS-12/2 BMDC, which do not produce type I IFN, have
significantly more RABV-N expression post infection
(Figure 8A). This indicates that in the absence of IFN-a/ß
induction, viral replication in DCs occurs at a faster rate, which
should also increase viral pathogenicity. Therefore, we infected
IPS-1 2/2, +/2,a n d+/+ mice, intramuscularly with SPBN-
N2c, a recombinant RABV that is modestly pathogenic after
peripheral inoculation [37]. Figure 8B shows that about 60% of
the IPS-1+/+ or +/2 mice lived, while only 45% of the IPS-1
2/2 mice survived infection. More dramatically, nearly 90% of
the IPS-12/2 mice had hind limb paralysis 11 days post
infection while the IPS-1+/+ and +/2 mice exhibited only
about 45% paralysis (Figure 8C). This data indicates that RABV
infection of IPS-12/2 is more pathogenic than RABV infection
in wildtype mice.
Figure 5. DC activation and IFN-production following RABV infection is dependent on IPS-1 signaling. CD86 expression on BMDCs
following RABV infection was analyzed by flow cytometry. (A) One representative knock-out and wildtype mouse is shown 12hpi. (B) For each sample
the fold increase in activation was determined by dividing the geometric mean fluorescent intensity (MFI) of the sample by the MFI of the uninfected
sample. Data is from three independent experiments and each point is representative of BMDCs from one mouse. (C) IFN-a/ß levels were monitored
by infectivity of VSV-GFP on reporter cells and an IFN-ß ELISA. The quantity of IFN-ß present in the supernatant of infected BMDCs is graphed here.
Additionally, the infection (+) or lack of infection (2) by VSV-GFP following a 24h pretreatment with cell supernatant is indicated above the graph.
Infection indicates viral replication, and thus, lack of type I IFN. (D) IL-6 levels were determined following infection of IPS-1 BMDCs by an ELISA.
Statistical significance was determined by T-test analysis and any significance is indicated, *p,0.05, **p,0.01, ***p,0.001. L.O.D. is limit of detection.
doi:10.1371/journal.ppat.1001016.g005
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It has been previously seen that RABV can infect APCs [28,29];
however, the impact of the infection on generating an innate
immune response to RABV had not been delineated. We show
here that following RABV infection of APCs, unlike fibroblasts or
neuronal cells, are able to produce copious amounts of type I IFN.
We also determined that infected APCs do not produce novel viral
progeny. A similar phenotype has also been seen following
influenza infection of DCs. BMDCs become infected by the
influenza strain, PR8, as seen by co-expression of influenza HA
and DC marker N418 on 72% of cells. However, infected BMDC
do not release viral progeny, as seen by a failure of infected DC
supernatants to induce hemagglutination of chicken red blood cells
[27]. Non-productive infection of DCs may have significant
biological relevance over the course of an infection. Since RABV
infection within APCs is easily controlled, the cells become a
source of viral antigen, with little risk of spreading infection to
neighboring cells. Taken together, APCs seem to be of critical
importance during a RABV infection both for the prolonged
production of type I IFN as well as a source of viral antigen.
In this study, we used APCs as a tool to study the PRRs used to
recognize RABV following infection. Interestingly, we see that
TLR-3 has no role in inducing a type I IFN response or DC
activation despite its previously recognized upregulation following
RABV infection [25]. However, recent publications may explain
this potential discrepancy. It was reported that TLR-3 is required
for the formation of Negri bodies in RABV infected cells and that
these bodies are the site of viral replication [38,39]. Furthermore,
TLR-3 2/2 mice are less susceptible to infection with pathogenic
RABV, as seen by increased survival and lower viral titers in the
brains of TLR-3 2/2 animals compared to wt mice [39]. Thus,
the requirement for TLR-3 by RABV may explain why it is
upregulated following infection despite the fact that it is not
required for a type I IFN response.
We next sought to identify whether TLR-7 was critical for DC
activation and type I IFN production. To our knowledge, no one
has directly examined the role of TLR-7 following a RABV
infection. Of note, TLR-7 signaling does play a role in the cellular
recognition of a closely related Rhabdovirus, VSV. Infection of
wild type plasmacytoid DCs (pDC) with VSV induced the
production of IFN-a. However, infection of pDCs from
TLR72/2 or MyD882/2 mice resulted in no cytokine
production [40]. Thus, indicating that single-stranded RNA
derived from VSV is able to trigger TLR-7 signaling. However,
in the case of RABV it appears that MyD88-dependent signaling,
and thus TLR-7, is dispensable for IFN-a/ß production following
infection.
On the other hand, RLR signaling via IPS-1 is critical for both
the activation of DCs and production of type I IFN by infected
DCs. It was shown previously that RIG-I signaling is necessary for
IFN-ß promoter activity in VERO cells following recombinant
RABV infection [24]. However, we show here using RIG-I2/2
derived DCs that Mda-5 is also able to induce DC activation and
type I IFN production. This is interesting, as Mda-5 is generally
recognized as a receptor for positive stranded RNA viruses, not
negative stranded RNA viruses like RABV. Of note, another
negative stranded RNA virus of the Paramyxoviridae family,
Sendai virus, requires MDA-5 signaling for the sustained
expression of type I IFN [41].
Our data indicates that RABV can be recognized by either
RIG-I or Mda-5 following infection. The use of both RIG-I and
Mda-5 receptors has also been observed following infection with
West Nile virus (WNV). Following WNV infection, RIG-I2/2
cells had a delayed upregulation of host anti-viral genes; however,
the ability to respond was conserved. Thus, indicating that another
receptor was involved in recognition of WNV, this receptor was
identified as Mda-5 [42,43]. Following RABV infection in the
absence of either RIG-I or Mda-5, there is a delay in the activation
of BMDCs. Furthermore, RIG-I2/2 BMDCs have an early
defect in type I IFN production. Thus, it appears that in response
to a RABV infection, both RIG-I and Mda-5 are utilized in order
to rapidly induce high levels of IFN-a/ß production and DC
activation.
Of note, IPS-1 +/2 cells exhibited a phenotype that was
intermediate to IPS-1 2/2 and IPS-1 +/+ mice. This observation
also supports the requirement for rapid induction of IFN-a/ß
following a RABV infection. The heterozygous cells are lacking
one of the IPS-1 alleles, and this may result in less functional
Table 2. Level of VSV-GFP replication on reporter cells following pre-treatment with UV-inactivated supernatants from TLR-agonist
stimulated BMDC.
LPS, 2ug/ml ODN1826, 2uM R848 1ug/ml poly(I:C) 50ug/ml DNS1/PR8
C57BL/6 22+ ND ND
MyD882/2 ++ ++ ++
BL6129SF1/J ++ 2 + 2 ND
TLR-32/2 ++ 2 ++
IPS-1+/+ + 2222
IPS-1+/2 + 2222
IPS-12/2 + 22++ +
C57BL/6 22+ 2 ND
Mda-52/2 22++
RIG-I +/+ + 2 + 2 ND
RIG-I 2/2 + 2 + 2
2: Less than 1% of reporter cells are infected.
+: Less than 50% of reporter cells are infected.
++: 100% of reporter cells are infected.
ND: not done.
doi:10.1371/journal.ppat.1001016.t002
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wildtype mice. This again highlights the importance of a rapid
response following viral infection in order to control viral
replication and spread.
The type I IFN response occurs in two phases after infection:
the induction of IFN-a/ß following recognition of the pathogen by
a PRR and then autocrine or paracrine signaling by IFN-a/ß
through the IFNAR to induce upregulation of many other genes.
Included among the genes that are upregulated in response to
IFNAR signaling are several genes required for PRR signal
transduction [2]. In this manner, the infected cell undergoes
positive feedback to increase both the host response and PRR
signaling. We wanted to identify which arm of the IFN response
was responsible for the effects we observed following RABV
infection of DCs, viral induction or IFN-a/ß amplification. We
saw that both wt and IFNAR 2/2 mice are able to induce type I
IFN production, thus highlighting the host’s ability to rapidly
induce IFN-a/ß following infection with RABV and indicating
that the amplification of IPS-1 signaling by IFNAR signaling is not
a critical factor in the induction of type I IFN. Surprisingly, we see
that in the absence of IFNAR signaling, there is very little BMDC
activation. Thus, it appears that DC activation occurs via IFN-a/ß
signaling and is not a direct consequence of viral infection. This
fact highlights the importance of a type I IFN response in initiating
the adaptive immune response following infection with RABV.
Lastly, we sought to determine the biological relevance of IPS-1
mediated PRR signaling following infection with a pathogenic
strain of RABV. Although this experiment did not focus
specifically on type I IFN production by DCs, it indicates how
IPS-1 signaling, and thus IFN-a/ß production and DC activation,
impacts the prognosis of infected animals. We saw that 87% of the
IPS-12/2 mice in the study became paralyzed, whereas only
about 45% of the IPS-1 +/+ or +/2 mice exhibited signs of
paralysis. There is some data that suggests paralysis following a
RABV infection is an early symptom of disease. In humans who
present with the less common paralytic rabies, their survival time is
slightly longer [44]. Although not significant, this data supports the
fact that an early, rapid type I IFN response is an important factor
mediating RABV disease outcome. Of note, opposed to vaccine
strain of RABV used in the BMDC experiments, the pathogenic
RABV strain, SPBN-N2c, infects mostly neurons [37] and we
showed here that RABV is able to suppress the type I IFN
response in neurons by 12hpi (Figure 1). Despite this limitation,
there is no other model to study RABV pathogenicity. The role
that antigen presenting cells play in initiating the immune response
to RABV in vivo should also be investigated further. It is known
Figure 6. RABV infection triggers IFN production and DC activation via either Mda-5 or RIG-I. CD86 expression on BMDC following RABV
infection was analyzed by flow cytometry 12, 24, and 48 h post infection. (A–B) For each sample the fold increase in activation was determined by
dividing the geometric mean fluorescent intensity (MFI) of the sample by the MFI of the uninfected sample for Mda-52/2 (A) and RIG-I2/2 (B). Each
point in A and B is representative of BMDCs from one mouse and data for RIG-I is representative of two independent experiments. (C) IFN-a/ß levels
were monitored by infectivity of VSV-GFP on reporter cells. Reporter cells were pre-treated with UV-inactivated BMDC supernatant from RABV
infection. 24h after supernatant was applied, reporter cells were infected with VSV-GFP. Fluorescence indicates viral replication, and thus, lack of type
I IFN. Statistical significance was determined by T-test analysis and any significance is indicated, *p,0.05, **p,0.01.
doi:10.1371/journal.ppat.1001016.g006
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RABV [45] thus it is likely that pathogenic RABV avoids or alters
infection of DC in order to elicit a lesser immune response.
In summary, we show here that RABV replication is cell type
dependent; namely, RABV is able to antagonize the induction of type
I IFN in fibroblast and neuronal cells but is unable to inhibit IFN-a/ß
induction in APCs. Furthermore, in APCs RABV infection is non-
productive due to a defect in viral transcription, and no viral
production is observed. Infection of BMDCs allowed us to delineate
that RABV is exclusively recognized by either RIG-I or Mda-5 and
both receptors are required for a rapid type I IFN response to RABV.
This finding has significant implications for the development of a
RABV-based vaccine vector. In light of these results, a recombinant
RABV expressing a TLR agonist may allow for RABV recognition
v i aT L R s .S u c har e s p o n s em a yp o t e n t i a t et h et y p eII F Nr e s p o n s e
and induce better protection in a vaccine setting. We also show here
that BMDC activation is secondary to IFN-a/ß induction and
requires IFNAR. In addition, IPS-1 mediated signaling does have a
role in vivo, as it seems to play a critical role in preventing RABV
pathogenesis following RABV challenge.
Materials and Methods
Ethics statement
All animals were handled in strict accordance with good animal
practice as defined by the relevant international (Association for
Assessment and Accreditation of Laboratory Animal Care
(AAALAC) (Accreditation Status TJU: Full)) and national (TJU
Animal Welfare Assurance Number: A3085-01), and all animal
work was approved by the Institutional Animal Care and Use
Committee (IACUC) at Thomas Jefferson University TJU. Animal
use protocols are written and approved in accordance with Public
Health Service Policy on Humane Care and Use of Laboratory
Animals, The Guide for the Care and Use of Laboratory Animals.
TJU IACUC protocol number 414A, 414G, and 414I were
utilized in this study.
Figure 7. IFN signaling is critical for DC activation. (A) IFN-a/ß levels were monitored by infectivity of VSV-GFP on reporter cells. Reporter cells
were pre-treated with UV-inactivated supernatant from IFNAR2/2 or Balb/c BMDC. 24h after supernatant was applied, reporter cells were infected
with VSV-GFP. Fluorescence indicates viral replication, and thus, lack of type I IFN. (B) One representative knock-out and wildtype mouse is shown
12hpi. (C–D) For each sample the fold increase in activation was determined by dividing the geometric mean fluorescent intensity (MFI) of the sample
by the MFI of the uninfected sample. In this manner, we looked at CD86 upregulation (C) and RABV-N expression (D) following RABV infection of
IFNAR2/2 or Balb/c BMDC 12, 24, and 48 hours post infection. Statistical significance was determined by T-test analysis and any significance is
indicated, *p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.ppat.1001016.g007
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PLoS Pathogens | www.plospathogens.org 11 July 2010 | Volume 6 | Issue 7 | e1001016Figure 8. Type I IFN produced via IPS-1 signaling affects RABV infection rates and viral pathogenicity. (A) IPS-1 BMDCs deficient in type
I IFN production (IPS-12/2 BMDC) are also more susceptible to RABV infection. The fold increase in RABV-N expression was determined by dividing
the geometric mean fluorescent intensity (MFI) of the sample by the MFI of the uninfected sample in IPS-1 BMDCs. (B–C) In two independent
experiments, IPS-12/2, +/2, and +/+ mice were infected intramuscularly with pathogenic SPBN-N2c and their survival (B) and hind limb paralysis (C)
was monitored over time. Statistical significance was determined by T-test analysis and any significance is indicated, *p,0.05, **p,0.01.
doi:10.1371/journal.ppat.1001016.g008
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The fibroblast cell line used in these studies is a cell clone of
BHK-21 (ATCC: CCL-10), BSR. The neuronal cell line used in
these studies is a neuroblastoma cell line referred to as NA [46].
The antigen presenting cell lines used here were JAWSII (ATCC:
CRL-11904) and Raw264.7 (ATCC: TIB-71).
Mice
Mice used in this work are as follows: B6/129S1-Tlr3tm1Flv/J
(TLR-3 2/2, Jackson Laboratory, stock 005217); B6129SF1/J
(Jackson Laboratory, stock 101043); MyD882/2 [47]; C57BL/6
(NIH); IPS-1 [48]; Mda-5 2/2 [33]; RIG-I [49]; BALB/c (NIH);
and IFNAR2/2 mice [50].
For pathogenicity study, IPS-1 mice were genotyped as
described previously [48]. IPS-1 +/+ (n=7), IPS-1 +/2 (n=13),
and IPS-1 2/2 (n=15) mice were infected intramuscularly with
10
6 ffu SBPN-N2c [37]. The weight of the mice was monitored
daily, and the animals were euthanized after losing 25% of their
body weight, which indicates a severe rabies infection.
IFN sensitivity assay
Cellular supernatants were assessed for the ability to inhibit
vesicular stomatitis virus (VSV) replication as described previously
[4]. Briefly, the cell line of interest was infected with the vaccine
strain of RABV, SPBN, at a multiplicity of infection (MOI) of 10,
and supernatant was collected at various time points post infection.
Alternatively, supernatant from infected BMDCs was used. The
supernatants were UV-deactivated with a 254nm UV light source
for 15 min. UV-deactivated viral supernatant was then diluted
1:10 in RPMI-1640 and added to a reporter cell line (either NA,
for cell line experiments or 3T3 cells, for BMDC experiements).
Following the 24 h pre-treatment, reporter cells were infected with
VSV- expressing GFP at a MOI of 5 for 5–8 h. VSV replication
was determined by fluorescence under a UV light source.
ELISA assays
For IFN-ß ELISA (PML Laboratories) the manufacturer’s
protocol was followed with the following modification: 50 mlo f
sample or standard was loaded into the 96-well plate. For IL-6
ELISA (eBioscience) the manufacturer’s protocol was followed.
Briefly, 5 mg/ml coating antibody was added to MaxiSorb (Nunc)
plates and kept at 4uC over night. Wells were then washed with
0.05% Tween-20/PBS and blocked with Assay Buffer
(eBioscience) for 2 hours. Plates were again washed with 0.05%
Tween-20/PBS and then 100 ml standard or sample and 50 ml
Biotin-Conjugate was added to the plate. Plates were incubated at
room temperature for 2 hours, on a microplate shaker set at
200 rpm, and then washed with 0.05% Tween-20/PBS. Subse-
quently, wells were incubated with Streptavidin-HRP at room
temperature for 1 hour, on a microplate shaker set at 200 rpm.
The wells were washed and developed with 100 ml of Substrate
Solution for 10 min followed by the addition of 100 ml of Stop
Solution. Absorbance at 450 nm was recorded for each well. For
both ELISAs a fourth-order non-linear regression curve (Prism
software, GraphPad version 4.00) was fit to the standard curve and
used to determine the concentration of the unknown samples.
One-step growth curve
BSR, NA, JAWSII and Raw264.7 cells were infected with
SPBN at a MOI of 10. Following 60 min incubation at 37uC, the
virus was aspirated, and cells were washed twice with PBS to
remove any virus that had not yet infected the cells. Media was
then added to the cells, and, at indicated time points, 0.3ml of
supernatant was removed and stored at 4uC. The aliquots were
titered in duplicate on BSR cells.
Quantitative real-time PCR
Messenger and genomic RABV-N RNA in SPBN (MOI-10)
infected BSR and JAWSII cells was determined by TaqMan
probe-based real-time PCR as described previously [4,37].
Western blotting
Western blotting was performed as described previously [51].
Bone marrow derived DC (BMDC) differentiation and
infection
BMDCs were differentiated as described previously [52].
Briefly, bone marrow (BM) was obtained from the mouse’s tibia
and femur. Following red blood cell lysis using ACK lysis buffer
(Invitrogen), the BM cells were cultured in 24-well costar plates at
a density of 1 million cells per ml in the presence of 10ng/ml GM-
CSF (Peprotech). During the 7 day culture, the cells were washed
once by aspirating 600ml of media from the wells and adding 1ml
of fresh media supplemented with 10ng/ml GM-CSF. On the
seventh day of culture, the non-adherent and semi-adherent cells
were collected and used as the BMDCs population.
BMDCs were plated in 12-well plates (Nunc) at a maximum
density of 1 million cells per ml of media. BMDCs were infected
with SPBN at an MOI of 10 or DNS1/PR8 [53] at an MOI of 1.
SPBN was harvested from BSR cells grown in serum free Opti-Pro
media 4 and 7 dpi. Viral supernatant was pooled and spun at
1600 rpm for 10 min to remove cell debris. Alternatively, cells
were left uninfected or stimulated with UV-deactivated SPBN,
LPS (2mg/ml, Sigma), ODN1826 (2mM, InvivoGen), R848 (1 mg/
ml, InvivoGen), or poly(I:C) (50 mg/ml, InvivoGen). Infected
BMDC were kept at 37uC with 5% CO2 for 12, 24, or 48 h.
Flow cytometry
Following differentiation of BMDC, cells were characterized for
expression of DC markers. Briefly, cells were washed in FACS
buffer (2% BSA/PBS) and blocked at 4uC for 30–60 m with 2ml
rat anti-mouse CD16/CD32 (Fc block) (BD Biosciences Pharmi-
gen) in 100ml FACS. Cells were then stained with APC-CD11b,
PerCP-B220, and FITC-CD11c (BD Biosciences Pharmingen) for
30 min at RT. After staining, cells were washed with FACS buffer
and fixed with Cytofix (BD Biosciences) for 16–18 hours at 4uC.
Samples were washed and resuspended in 300 ml of FACS buffer.
Samples were analyzed on BD FACS Calibur and a minimum of
50,000 events were counted.
Following infection, BMDCs were analyzed for the expression of
activationmarkers.Ateach giventimepoint,BMDCswereremoved
from wells with cell scrappers and spun at 1600rpm for 5 min. Cells
were then blocked at 4uC for 30–60 min with Fc block in 100ml
FACS. Cells were then stained with APC-CD11c and PE-CD86
(BD Biosciences Pharmingen) for 30 min at RT. After staining, cells
were washed with FACS buffer and fixed with Cytofix (BD
Biosciences) for 16–18 hours at 4uC. Cells were then washed twice
in Perm/Wash Buffer (BD Bioscience) and then stained with FITC-
anti RABV-N (Centacor, Inc) for 30 min at RT. After staining, cells
were washed with Perm/Wash buffer and then resuspended in
300 ml of FACS buffer. Samples were analyzed on BD FACS
Calibur and 20,000–30,000 APC
+ events were counted.
Statistical analysis
All data were analyzed by Prism software (GraphPad, version
4.00). To compare two groups of data we used an un-paired, two-
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indicate significance between two groups: *p,0.05, **p,0.01,
***p,0.001.
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